The Norwegian medtech company, Respinor, has created an innovative technology called DiaMon, which provides real-time information on the function of the diaphragm, the main breathing muscle. The device is designed for critically ill patients in intensive care and has potential applications in respiratory medicine. Respinor aims to capture a significant market opportunity by validating, maturing, and commercializing this unique ultrasound technology. The company's technology has won the Horizon 2020 award in both phases I and II, and it addresses an unmet medical need by providing doctors with objective measures of breathing to improve the quality of care and reduce costs.